Bypass of premature stop codons and generation of functional BRCA2 by exon skipping
- 11 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Human Genetics
- Vol. 65 (9), 805-809
- https://doi.org/10.1038/s10038-020-0768-0
Abstract
A pathogenic mutation in BRCA2 significantly increases the risk of breast and ovarian cancers making it imperative to examine the functional consequences of variants of uncertain clinical significance. Variants that are predicted to result in a truncated protein are unambiguously classified as pathogenic. We have previously shown how a pathogenic splice site variant known to generate a premature termination codon (PTC) in exon 9 and a nonsense mutation at exon 7, can generate functional BRCA2 by skipping exons 4-7 and restoring the reading frame. Using a well-established mouse embryonic stem cell-based assay, we functionally characterize here one splice site mutation and 11 pathogenic BRCA2 variants that are either nonsense mutation or generate PTC in different exons ranging from exons 4 to 7. Our study shows that five variants can restore the open reading frame by exon skipping and generate a functional protein. This suggests further need to exercise prudence when classifying clearly pathogenic variants.Keywords
Funding Information
- Intramural Research Program, Center for Cancer Research, National Cancer Institute, U.S. National Institutes of Health
This publication has 15 references indexed in Scilit:
- Lessons learned from two decades of BRCA1 and BRCA2 genetic testing: the evolution of data sharing and variant classificationGenetics in Medicine, 2019
- BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2PLoS Genetics, 2018
- DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessmentJournal of Medical Genetics, 2017
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersJAMA, 2017
- BRCA2 minor transcript lacking exons 4–7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutationHuman Molecular Genetics, 2016
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesHuman Mutation, 2011
- A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell–based assayBlood, 2011
- Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2Nature Medicine, 2008
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- The BRCA2 genetic variant IVS7 + 2T → G is a mutationJournal of Human Genetics, 2000